Depth of radiographic response (DpR) and time to tumor regrowth (TTG) predicts overall survival following anti-VEGF therapy in recurrent glioblastoma.

Benjamin M Ellingson Akifumi Hagiwara Connor J Morris Nicholas S Cho Sonoko Oshima Francesco Sanvito Talia C Oughourlian Donatello Telesca Catalina Raymond Lauren E Abrey Josep Garcia Dana T Aftab Colin Hessel Tamar Rachmilewitz Minei Dror Harats David A Nathanson Patrick Yung Wen Timothy F Cloughesy

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)

Recurrent glioblastoma patients with a large, durable radiographic response to anti-angiogenic agents have significantly longer survival. This information is useful for interpreting activity of anti-angiogenic agents in recurrent glioblastoma.

Keyphrases

endothelial cells
healthcare
stem cells
vascular endothelial growth factor
health information